{
  "params": {
    "ind": "药品及生物科技",
    "sort": "ygc",
    "page": 2,
    "q": "",
    "sig": false,
    "fcf": "",
    "screen": false,
    "big": false,
    "mine": false
  },
  "pages": 2,
  "count": 170,
  "fcf_counts": {
    "all": 170,
    "end": 18,
    "yoy": 3,
    "trend": 19
  },
  "cap_counts": {
    "all": 170,
    "big": 34
  },
  "mine_counts": {
    "all": 170,
    "mine": 0
  },
  "watch_count": 0,
  "watch_updated": null,
  "triggered": 7,
  "details_updated_bj": "2026-10-17 13:54",
  "universe_updated_bj": "2026-10-17 13:49",
  "quotes_updated_bj": "2026-10-17 14:00",
  "quote_source": "腾讯",
  "a_updated_bj": "2026-10-17 14:00",
  "hkd_cny": 0.8517,
  "ah_count": 176,
  "main_period": "2026-06-30",
  "coverage": {
    "2026-06-30": 1995,
    "2025-06-30": 47,
    "2026-03-31": 403,
    "2024-12-31": 15,
    "2026-01-31": 7,
    "2025-12-31": 26,
    "2026-04-30": 15,
    "2025-10-31": 1,
    "2026-02-28": 23,
    "2025-09-30": 4,
    "2025-03-31": 4,
    "2026-09-30": 3,
    "2026-05-31": 8
  },
  "fcf_years": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025"
  ],
  "missing": [],
  "rows": [
    {
      "code": "02509",
      "name": "荃信生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 16,
      "market_cap_yi": 30.4,
      "ev_yi": 37.8,
      "ee": 6.9,
      "loss": false,
      "ygc": -0.47,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 10.7,
        "cash_yi": 3.25,
        "np_ttm_yi": 5.46,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1.8,
          -2.5,
          -3.1,
          -1.9,
          3.9
        ],
        "fcf_avg_yi": -1.08,
        "ibd_yi": 6.87,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -14.420000000000002
      },
      "revenue_ttm_yi": 10.25,
      "net_margin": 53.3,
      "roe_by_year": {
        "2023": -108.4377,
        "2024": -128.145,
        "2025": 68.1361
      },
      "roe_avg": -56.15,
      "common_equity_yi": 8.6102,
      "pb": 3.53,
      "roe_pb": -15.9,
      "watched": false
    },
    {
      "code": "09886",
      "name": "叮当健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.855,
      "market_cap_yi": 8.9,
      "ev_yi": 12.5,
      "ee": null,
      "loss": true,
      "ygc": -0.49,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 13.06,
        "cash_yi": 9.39,
        "np_ttm_yi": -0.62,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.2,
          -2.7,
          -0.3,
          -0.4,
          1
        ],
        "fcf_avg_yi": -1.12,
        "ibd_yi": 2.62,
        "k": 0.993,
        "k_src": "equity",
        "iv_yi": -4.3989899999999995
      },
      "revenue_ttm_yi": 49.7,
      "net_margin": -1.2,
      "roe_by_year": {
        "2023": -10.694,
        "2024": -20.3643,
        "2025": -2.9496
      },
      "roe_avg": -11.34,
      "common_equity_yi": 15.2514,
      "pb": 0.58,
      "roe_pb": -19.43,
      "watched": false
    },
    {
      "code": "02396",
      "name": "青城新药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.83,
      "market_cap_yi": 3.8,
      "ev_yi": -1.2,
      "ee": null,
      "loss": true,
      "ygc": -0.51,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.37,
        "cash_yi": 5.36,
        "np_ttm_yi": -2.44,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -0.5,
          -0.6,
          -1,
          -0.8
        ],
        "fcf_avg_yi": -0.7250000000000001,
        "ibd_yi": 0.04,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -1.9300000000000006
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": 112.6138,
        "2024": -2274.7977,
        "2025": -53.9231
      },
      "roe_avg": -738.7,
      "common_equity_yi": 5.5642,
      "pb": 0.68,
      "roe_pb": -1081.65,
      "watched": false
    },
    {
      "code": "06998",
      "name": "亿腾嘉和",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.645,
      "market_cap_yi": 27.6,
      "ev_yi": 39.6,
      "ee": 18.1,
      "loss": false,
      "ygc": -0.54,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 21.13,
        "cash_yi": 9.13,
        "np_ttm_yi": 2.19,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -7,
          -5.9,
          -4.3,
          7.1,
          4
        ],
        "fcf_avg_yi": -1.22,
        "ibd_yi": 11.82,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -14.889999999999999
      },
      "revenue_ttm_yi": 22.25,
      "net_margin": 9.8,
      "roe_by_year": {
        "2023": -45.0883,
        "2024": -4.3826,
        "2025": 12.7491
      },
      "roe_avg": -12.24,
      "common_equity_yi": 39.8015,
      "pb": 0.69,
      "roe_pb": -17.65,
      "watched": false
    },
    {
      "code": "02196",
      "name": "复星医药",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 17.11,
      "market_cap_yi": 564,
      "ev_yi": 1020,
      "ee": 30.1,
      "loss": false,
      "ygc": -0.57,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 620.26,
        "cash_yi": 94.87,
        "np_ttm_yi": 33.9,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10.3,
          -16.7,
          -19.2,
          0.7,
          7.6
        ],
        "fcf_avg_yi": -7.58,
        "ibd_yi": 390.32,
        "k": 0.868,
        "k_src": "profit",
        "iv_yi": -322.245
      },
      "revenue_ttm_yi": 424.49,
      "net_margin": 8,
      "roe_by_year": {
        "2023": 5.3197,
        "2024": 5.9651,
        "2025": 7.0274
      },
      "roe_avg": 6.1,
      "common_equity_yi": 486.9282,
      "pb": 1.16,
      "roe_pb": 5.27,
      "watched": false
    },
    {
      "code": "02652",
      "name": "长风药业",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 5.98,
      "market_cap_yi": 22,
      "ev_yi": 22.4,
      "ee": null,
      "loss": true,
      "ygc": -0.58,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.95,
        "cash_yi": 3.51,
        "np_ttm_yi": -0.07,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.5,
          -0.8,
          -0.2,
          -1,
          -2.6
        ],
        "fcf_avg_yi": -1.42,
        "ibd_yi": 2.12,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -12.81
      },
      "revenue_ttm_yi": 4.37,
      "net_margin": -1.6,
      "roe_by_year": {
        "2023": 3.5809,
        "2024": 2.2806,
        "2025": 0.2064
      },
      "roe_avg": 2.02,
      "common_equity_yi": 13.4208,
      "pb": 1.64,
      "roe_pb": 1.23,
      "watched": false
    },
    {
      "code": "02627",
      "name": "中慧生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 29.32,
      "market_cap_yi": 98.2,
      "ev_yi": 111.4,
      "ee": null,
      "loss": true,
      "ygc": -0.59,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 14.24,
        "cash_yi": 1.08,
        "np_ttm_yi": -2.24,
        "period": "2025-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          null,
          -6,
          -4,
          null
        ],
        "fcf_avg_yi": -5,
        "ibd_yi": 9.16,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -58.08
      },
      "revenue_ttm_yi": 3.24,
      "net_margin": -69.1,
      "roe_by_year": {
        "2023": -116.9216,
        "2024": -101.4857
      },
      "roe_avg": -109.2,
      "common_equity_yi": 0.3366,
      "pb": 291.74,
      "roe_pb": -0.37,
      "watched": false
    },
    {
      "code": "01875",
      "name": "东曜药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.515,
      "market_cap_yi": 23.1,
      "ev_yi": 26.1,
      "ee": null,
      "loss": true,
      "ygc": -0.61,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.59,
        "cash_yi": 2.57,
        "np_ttm_yi": -1.63,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.9,
          -1.8,
          -1.5,
          -0.1,
          -0.3
        ],
        "fcf_avg_yi": -1.3199999999999998,
        "ibd_yi": 3.51,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -14.14
      },
      "revenue_ttm_yi": 5.05,
      "net_margin": -32.3,
      "roe_by_year": {
        "2023": -5.3917,
        "2024": 4.908,
        "2025": -14.8095
      },
      "roe_avg": -5.1,
      "common_equity_yi": 6.1471,
      "pb": 3.76,
      "roe_pb": -1.36,
      "watched": false
    },
    {
      "code": "00767",
      "name": "中基长寿科学",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.485,
      "market_cap_yi": 2.6,
      "ev_yi": 3.4,
      "ee": null,
      "loss": true,
      "ygc": -0.62,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.99,
        "cash_yi": 0.12,
        "np_ttm_yi": -0.09,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.3,
          0.1,
          0.1,
          -0.6,
          -0.2
        ],
        "fcf_avg_yi": -0.18,
        "ibd_yi": 0.05,
        "k": 0.935,
        "k_src": "equity",
        "iv_yi": -1.61755
      },
      "revenue_ttm_yi": 1.64,
      "net_margin": -5.5,
      "roe_by_year": {
        "2023": 0.5803,
        "2024": -8.9405,
        "2025": -4.3442
      },
      "roe_avg": -4.23,
      "common_equity_yi": 3.5544,
      "pb": 0.73,
      "roe_pb": -5.79,
      "watched": false
    },
    {
      "code": "00858",
      "name": "精优药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.071,
      "market_cap_yi": 1.8,
      "ev_yi": 2.9,
      "ee": null,
      "loss": true,
      "ygc": -0.62,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 1.87,
        "cash_yi": 0.79,
        "np_ttm_yi": -8.65,
        "period": "2026-03-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.1,
          0,
          0,
          -0.1,
          0
        ],
        "fcf_avg_yi": -0.04,
        "ibd_yi": 1.5,
        "k": 0.999,
        "k_src": "equity",
        "iv_yi": -1.10889
      },
      "revenue_ttm_yi": 0.45,
      "net_margin": -1922.2,
      "roe_by_year": {
        "2023": -13.6083,
        "2024": 18.1923,
        "2025": -114.6103
      },
      "roe_avg": -36.68,
      "common_equity_yi": 3.3119,
      "pb": 0.54,
      "roe_pb": -67.48,
      "watched": false
    },
    {
      "code": "02105",
      "name": "来凯医药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 6.6,
      "market_cap_yi": 25.4,
      "ev_yi": 18.1,
      "ee": null,
      "loss": true,
      "ygc": -0.63,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.06,
        "cash_yi": 9.4,
        "np_ttm_yi": -1.02,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.1,
          -3.1,
          -3,
          -2.8,
          -0.9
        ],
        "fcf_avg_yi": -2.38,
        "ibd_yi": 1.56,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -15.959999999999996
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": 66.9892,
        "2024": -31.6138,
        "2025": -23.1034
      },
      "roe_avg": 4.09,
      "common_equity_yi": 11.9904,
      "pb": 2.12,
      "roe_pb": 1.93,
      "watched": false
    },
    {
      "code": "01167",
      "name": "加科思-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 5.225,
      "market_cap_yi": 34.8,
      "ev_yi": 38,
      "ee": 7.4,
      "loss": false,
      "ygc": -0.66,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.12,
        "cash_yi": 1.92,
        "np_ttm_yi": 5.14,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1.6,
          -3.1,
          -4,
          -0.9,
          -2.1
        ],
        "fcf_avg_yi": -2.34,
        "ibd_yi": 1.6,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -23.08
      },
      "revenue_ttm_yi": 7.39,
      "net_margin": 69.6,
      "roe_by_year": {
        "2023": -30.4868,
        "2024": -15.5978,
        "2025": -17.237
      },
      "roe_avg": -21.11,
      "common_equity_yi": 13.5154,
      "pb": 2.57,
      "roe_pb": -8.2,
      "watched": false
    },
    {
      "code": "02171",
      "name": "科济药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 11.66,
      "market_cap_yi": 59,
      "ev_yi": 49.9,
      "ee": null,
      "loss": true,
      "ygc": -0.66,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.87,
        "cash_yi": 14,
        "np_ttm_yi": -0.89,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -6.9,
          -7.8,
          -4.6,
          -4.3,
          -2.4
        ],
        "fcf_avg_yi": -5.199999999999999,
        "ibd_yi": 0.72,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -38.71999999999999
      },
      "revenue_ttm_yi": 1.37,
      "net_margin": -65,
      "roe_by_year": {
        "2023": -34.9855,
        "2024": -55.8445,
        "2025": -10.6369
      },
      "roe_avg": -33.82,
      "common_equity_yi": 11.0039,
      "pb": 5.36,
      "roe_pb": -6.31,
      "watched": false
    },
    {
      "code": "06185",
      "name": "康希诺生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 30.32,
      "market_cap_yi": 129.1,
      "ev_yi": 135.9,
      "ee": 331.3,
      "loss": false,
      "ygc": -0.68,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 18.47,
        "cash_yi": 11.72,
        "np_ttm_yi": 0.41,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          8.1,
          -29.6,
          -15.3,
          -6.3,
          -1.7
        ],
        "fcf_avg_yi": -8.959999999999999,
        "ibd_yi": 9.81,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -87.69
      },
      "revenue_ttm_yi": 12.32,
      "net_margin": 3.3,
      "roe_by_year": {
        "2023": -24.6656,
        "2024": -7.4404,
        "2025": 0.5652
      },
      "roe_avg": -10.51,
      "common_equity_yi": 49.7785,
      "pb": 2.59,
      "roe_pb": -4.05,
      "watched": false
    },
    {
      "code": "02656",
      "name": "健康160",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.49,
      "market_cap_yi": 7.4,
      "ev_yi": 9.3,
      "ee": null,
      "loss": true,
      "ygc": -0.7,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 6.18,
        "cash_yi": 4.27,
        "np_ttm_yi": -0.52,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.1,
          -0.4,
          -0.7,
          -0.6,
          -1.2
        ],
        "fcf_avg_yi": -0.6,
        "ibd_yi": 3.48,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -5.210000000000001
      },
      "revenue_ttm_yi": 6.8,
      "net_margin": -7.6,
      "roe_by_year": {
        "2023": 51.5994,
        "2024": 175.2675,
        "2025": -94.8529
      },
      "roe_avg": 44,
      "common_equity_yi": 2.3914,
      "pb": 3.09,
      "roe_pb": 14.22,
      "watched": false
    },
    {
      "code": "01312",
      "name": "华控康泰",
      "l1": "药品及生物科技",
      "l2": "红筹股",
      "price": 0.032,
      "market_cap_yi": 1.5,
      "ev_yi": 5.9,
      "ee": null,
      "loss": true,
      "ygc": -0.71,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.03,
        "cash_yi": 0.59,
        "np_ttm_yi": -1.87,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          -0.5,
          0.1,
          0.3,
          0.5
        ],
        "fcf_avg_yi": 0,
        "ibd_yi": 1.65,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -1.06
      },
      "revenue_ttm_yi": 7.46,
      "net_margin": -25.1,
      "roe_by_year": {
        "2023": -2.6726,
        "2024": -7.4202,
        "2025": -55.8561
      },
      "roe_avg": -21.98,
      "common_equity_yi": 4.4314,
      "pb": 0.34,
      "roe_pb": -64.94,
      "watched": false
    },
    {
      "code": "02617",
      "name": "药捷安康-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 9.275,
      "market_cap_yi": 32.2,
      "ev_yi": 29,
      "ee": null,
      "loss": true,
      "ygc": -0.72,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 1.09,
        "cash_yi": 4.25,
        "np_ttm_yi": -2.69,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -2.5,
          -3.3,
          -2.7,
          -2.5
        ],
        "fcf_avg_yi": -2.75,
        "ibd_yi": 0.06,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -23.31
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -36.6331,
        "2024": -41.9825,
        "2025": -62.8768
      },
      "roe_avg": -47.16,
      "common_equity_yi": 8.7799,
      "pb": 3.67,
      "roe_pb": -12.86,
      "watched": false
    },
    {
      "code": "02575",
      "name": "轩竹生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 8.28,
      "market_cap_yi": 36.5,
      "ev_yi": 34,
      "ee": null,
      "loss": true,
      "ygc": -0.73,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.53,
        "cash_yi": 5.08,
        "np_ttm_yi": -2.1,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -5.5,
          -2.6,
          -2.1,
          -2.5
        ],
        "fcf_avg_yi": -3.175,
        "ibd_yi": 0,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -26.67
      },
      "revenue_ttm_yi": 1.03,
      "net_margin": -203.9,
      "roe_by_year": {
        "2023": -24.5478,
        "2024": -53.8404,
        "2025": -21.1012
      },
      "roe_avg": -33.16,
      "common_equity_yi": 12.9491,
      "pb": 2.82,
      "roe_pb": -11.77,
      "watched": false
    },
    {
      "code": "09637",
      "name": "礼邦医药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 17.48,
      "market_cap_yi": 51.9,
      "ev_yi": 46,
      "ee": null,
      "loss": true,
      "ygc": -0.74,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 7.55,
        "cash_yi": 13.45,
        "np_ttm_yi": -7.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          null,
          -5,
          -4.9,
          -3.9
        ],
        "fcf_avg_yi": -4.6000000000000005,
        "ibd_yi": 5.77,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -38.32000000000001
      },
      "revenue_ttm_yi": 1.23,
      "net_margin": -572.4,
      "roe_by_year": {
        "2023": 47.888,
        "2024": 31.1766,
        "2025": 181.3559
      },
      "roe_avg": 86.81,
      "common_equity_yi": 14.0855,
      "pb": 3.68,
      "roe_pb": 23.56,
      "watched": false
    },
    {
      "code": "02629",
      "name": "MIRXES-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 12.41,
      "market_cap_yi": 31.5,
      "ev_yi": 30,
      "ee": null,
      "loss": true,
      "ygc": -0.76,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.49,
        "cash_yi": 5.14,
        "np_ttm_yi": -5.5,
        "period": "2025-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1.3,
          -5,
          -3.3,
          -2.3,
          null
        ],
        "fcf_avg_yi": -2.9749999999999996,
        "ibd_yi": 1.66,
        "k": 0.912,
        "k_src": "equity",
        "iv_yi": -23.958239999999996
      },
      "revenue_ttm_yi": 1.53,
      "net_margin": -359.5,
      "roe_by_year": {
        "2022": 165.1156,
        "2023": 70.3465,
        "2024": 54.0476
      },
      "roe_avg": 96.5,
      "common_equity_yi": 7.4764,
      "pb": 4.21,
      "roe_pb": 22.9,
      "watched": false
    },
    {
      "code": "02898",
      "name": "盛禾生物-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 6.39,
      "market_cap_yi": 8.5,
      "ev_yi": 7.6,
      "ee": null,
      "loss": true,
      "ygc": -0.76,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.77,
        "cash_yi": 1.71,
        "np_ttm_yi": -0.82,
        "period": "2025-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.6,
          -0.4,
          -0.4,
          -1.6,
          null
        ],
        "fcf_avg_yi": -0.75,
        "ibd_yi": 0.68,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -6.47
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2022": 78.1487,
        "2023": 251.3086,
        "2024": -39.215
      },
      "roe_avg": 96.75,
      "common_equity_yi": 4.8127,
      "pb": 1.77,
      "roe_pb": 54.78,
      "watched": false
    },
    {
      "code": "02181",
      "name": "迈博药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.5,
      "market_cap_yi": 17.6,
      "ev_yi": 26.4,
      "ee": 30.7,
      "loss": false,
      "ygc": -0.77,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 9.75,
        "cash_yi": 0.93,
        "np_ttm_yi": 0.86,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.5,
          -1.8,
          0.4,
          -0.6,
          -0.2
        ],
        "fcf_avg_yi": -1.14,
        "ibd_yi": 3.08,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -13.549999999999999
      },
      "revenue_ttm_yi": 7.7,
      "net_margin": 11.2,
      "roe_by_year": {
        "2023": -69.0943,
        "2024": -87.0414,
        "2025": 46.4047
      },
      "roe_avg": -36.58,
      "common_equity_yi": 1.9384,
      "pb": 9.08,
      "roe_pb": -4.03,
      "watched": false
    },
    {
      "code": "02348",
      "name": "东瑞制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.94,
      "market_cap_yi": 12.1,
      "ev_yi": 14.6,
      "ee": 6.3,
      "loss": false,
      "ygc": -0.78,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.56,
        "cash_yi": 3.03,
        "np_ttm_yi": 2.33,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.6,
          -4.7,
          1.3,
          0.4,
          2.4
        ],
        "fcf_avg_yi": -1.2399999999999998,
        "ibd_yi": 0.04,
        "k": 1,
        "k_src": "profit",
        "iv_yi": -9.409999999999998
      },
      "revenue_ttm_yi": 11.46,
      "net_margin": 20.3,
      "roe_by_year": {
        "2023": 11.8619,
        "2024": 18.286,
        "2025": 6.3783
      },
      "roe_avg": 12.18,
      "common_equity_yi": 34.3218,
      "pb": 0.35,
      "roe_pb": 34.54,
      "watched": false
    },
    {
      "code": "01877",
      "name": "君实生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 16.31,
      "market_cap_yi": 265.8,
      "ev_yi": 317.4,
      "ee": null,
      "loss": true,
      "ygc": -0.83,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 80.5,
        "cash_yi": 27.06,
        "np_ttm_yi": -4.02,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -14.1,
          -21.6,
          -28.5,
          -21.3,
          -12.8
        ],
        "fcf_avg_yi": -19.66,
        "ibd_yi": 59.14,
        "k": 0.966,
        "k_src": "equity",
        "iv_yi": -220.90488
      },
      "revenue_ttm_yi": 30.26,
      "net_margin": -13.3,
      "roe_by_year": {
        "2023": -27.3703,
        "2024": -19.6546,
        "2025": -14.1026
      },
      "roe_avg": -20.38,
      "common_equity_yi": 59.5966,
      "pb": 4.46,
      "roe_pb": -4.57,
      "watched": false
    },
    {
      "code": "02563",
      "name": "华昊中天医药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.8,
      "market_cap_yi": 12.6,
      "ev_yi": 9.1,
      "ee": null,
      "loss": true,
      "ygc": -0.84,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 1.01,
        "cash_yi": 4.47,
        "np_ttm_yi": -1.04,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -1.1,
          -1.8,
          -1.5,
          -1.6
        ],
        "fcf_avg_yi": -1.5,
        "ibd_yi": 0.01,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -10.54
      },
      "revenue_ttm_yi": 0.55,
      "net_margin": -189.1,
      "roe_by_year": {
        "2023": -23.8383,
        "2024": -18.994,
        "2025": -18.044
      },
      "roe_avg": -20.29,
      "common_equity_yi": 6.3987,
      "pb": 1.97,
      "roe_pb": -10.31,
      "watched": false
    },
    {
      "code": "02157",
      "name": "乐普生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.52,
      "market_cap_yi": 54.1,
      "ev_yi": 65,
      "ee": 26.3,
      "loss": false,
      "ygc": -0.87,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 17.79,
        "cash_yi": 6.85,
        "np_ttm_yi": 2.47,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -8.4,
          -5.9,
          -2.9,
          -2.6,
          -1.3
        ],
        "fcf_avg_yi": -4.220000000000001,
        "ibd_yi": 11.8,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -47.15
      },
      "revenue_ttm_yi": 9.91,
      "net_margin": 24.9,
      "roe_by_year": {
        "2023": -2.4583,
        "2024": -51.4307,
        "2025": 25.0213
      },
      "roe_avg": -9.62,
      "common_equity_yi": 14.132,
      "pb": 3.83,
      "roe_pb": -2.51,
      "watched": false
    },
    {
      "code": "06855",
      "name": "亚盛医药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 29.74,
      "market_cap_yi": 95,
      "ev_yi": 105.9,
      "ee": null,
      "loss": true,
      "ygc": -0.89,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 26.75,
        "cash_yi": 15.67,
        "np_ttm_yi": -14.69,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10.4,
          -8.9,
          -7.8,
          -1.4,
          -12
        ],
        "fcf_avg_yi": -8.1,
        "ibd_yi": 20.95,
        "k": 0.983,
        "k_src": "equity",
        "iv_yi": -84.81324
      },
      "revenue_ttm_yi": 6.43,
      "net_margin": -228.5,
      "roe_by_year": {
        "2023": -394.6648,
        "2024": -249.7962,
        "2025": -156.4554
      },
      "roe_avg": -266.97,
      "common_equity_yi": 5.5639,
      "pb": 17.07,
      "roe_pb": -15.64,
      "watched": false
    },
    {
      "code": "02480",
      "name": "绿竹生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 15.3,
      "market_cap_yi": 25.9,
      "ev_yi": 28.6,
      "ee": null,
      "loss": true,
      "ygc": -0.91,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.97,
        "cash_yi": 1.27,
        "np_ttm_yi": -1.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1,
          -3.3,
          -2.8,
          -1.8,
          -1.9
        ],
        "fcf_avg_yi": -2.16,
        "ibd_yi": 3.14,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -23.470000000000002
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -25.4686,
        "2024": -17.9525,
        "2025": -19.8658
      },
      "roe_avg": -21.1,
      "common_equity_yi": 5.985,
      "pb": 4.33,
      "roe_pb": -4.87,
      "watched": false
    },
    {
      "code": "02616",
      "name": "基石药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 4.97,
      "market_cap_yi": 67.6,
      "ev_yi": 61.3,
      "ee": null,
      "loss": true,
      "ygc": -0.92,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 7.63,
        "cash_yi": 13.95,
        "np_ttm_yi": -4.19,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -16.3,
          -7.1,
          -6.5,
          -3,
          -3.3
        ],
        "fcf_avg_yi": -7.239999999999999,
        "ibd_yi": 3.57,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -62.01999999999998
      },
      "revenue_ttm_yi": 4.25,
      "net_margin": -98.6,
      "roe_by_year": {
        "2023": -81.0532,
        "2024": -22.2266,
        "2025": -89.1261
      },
      "roe_avg": -64.14,
      "common_equity_yi": 12.925,
      "pb": 5.23,
      "roe_pb": -12.26,
      "watched": false
    },
    {
      "code": "02186",
      "name": "绿叶制药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.705,
      "market_cap_yi": 58,
      "ev_yi": 138.5,
      "ee": 19.9,
      "loss": false,
      "ygc": -0.94,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 172.97,
        "cash_yi": 82.16,
        "np_ttm_yi": 6.96,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -13.6,
          4.9,
          4.3,
          -15.4,
          7.8
        ],
        "fcf_avg_yi": -2.4,
        "ibd_yi": 119.87,
        "k": 0.886,
        "k_src": "equity",
        "iv_yi": -54.67506000000001
      },
      "revenue_ttm_yi": 61.29,
      "net_margin": 11.4,
      "roe_by_year": {
        "2023": 4.6911,
        "2024": 3.5366,
        "2025": 4.094
      },
      "roe_avg": 4.11,
      "common_equity_yi": 153.2448,
      "pb": 0.38,
      "roe_pb": 10.85,
      "watched": false
    },
    {
      "code": "02493",
      "name": "迈威生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 19.13,
      "market_cap_yi": 96.7,
      "ev_yi": 112.8,
      "ee": null,
      "loss": true,
      "ygc": -0.94,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 42.41,
        "cash_yi": 22.94,
        "np_ttm_yi": -9.4,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          null,
          -12.8,
          -12.9,
          -4.5
        ],
        "fcf_avg_yi": -10.066666666666668,
        "ibd_yi": 31.63,
        "k": 0.828,
        "k_src": "equity",
        "iv_yi": -90.54732000000001
      },
      "revenue_ttm_yi": 8.7,
      "net_margin": -108,
      "roe_by_year": {
        "2023": -40.7722,
        "2024": -50.2781,
        "2025": -101.0573
      },
      "roe_avg": -64.04,
      "common_equity_yi": 8.7349,
      "pb": 11.07,
      "roe_pb": -5.78,
      "watched": false
    },
    {
      "code": "02659",
      "name": "宝济药业-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 9.6,
      "market_cap_yi": 26.4,
      "ev_yi": 23.2,
      "ee": null,
      "loss": true,
      "ygc": -0.97,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 7.21,
        "cash_yi": 10.42,
        "np_ttm_yi": -3.66,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          null,
          -2.8,
          -3.4,
          -3.3
        ],
        "fcf_avg_yi": -3.1666666666666665,
        "ibd_yi": 4.23,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -25.47666666666666
      },
      "revenue_ttm_yi": 0.17,
      "net_margin": -2152.9,
      "roe_by_year": {
        "2023": -21.411,
        "2024": -41.7688,
        "2025": -30.5506
      },
      "roe_avg": -31.24,
      "common_equity_yi": 14.4872,
      "pb": 1.82,
      "roe_pb": -17.15,
      "watched": false
    },
    {
      "code": "09688",
      "name": "再鼎医药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 18.6,
      "market_cap_yi": 180.3,
      "ev_yi": 163.9,
      "ee": null,
      "loss": true,
      "ygc": -1.04,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 31.86,
        "cash_yi": 48.26,
        "np_ttm_yi": -12.89,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -36.2,
          -27.3,
          -14.6,
          -19.9,
          -11.5
        ],
        "fcf_avg_yi": -21.9,
        "ibd_yi": 17.34,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -188.08
      },
      "revenue_ttm_yi": 30.87,
      "net_margin": -41.8,
      "roe_by_year": {
        "2023": -36.3379,
        "2024": -31.4112,
        "2025": -22.5568
      },
      "roe_avg": -30.1,
      "common_equity_yi": 41.3447,
      "pb": 4.36,
      "roe_pb": -6.9,
      "watched": false
    },
    {
      "code": "02591",
      "name": "银诺医药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.645,
      "market_cap_yi": 14.2,
      "ev_yi": 9.3,
      "ee": null,
      "loss": true,
      "ygc": -1.08,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.58,
        "cash_yi": 8.47,
        "np_ttm_yi": -3.34,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -2.2,
          -1.8,
          -1.7,
          -3.2
        ],
        "fcf_avg_yi": -2.225,
        "ibd_yi": 1.51,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -15.290000000000001
      },
      "revenue_ttm_yi": 1.53,
      "net_margin": -218.3,
      "roe_by_year": {
        "2023": -117.693,
        "2024": -23.2672,
        "2025": -36.9067
      },
      "roe_avg": -59.29,
      "common_equity_yi": 9.4195,
      "pb": 1.51,
      "roe_pb": -39.33,
      "watched": false
    },
    {
      "code": "01011",
      "name": "泰凌医药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.3,
      "market_cap_yi": 4.6,
      "ev_yi": 11.4,
      "ee": null,
      "loss": true,
      "ygc": -1.09,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 6.94,
        "cash_yi": 0.12,
        "np_ttm_yi": -0.28,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1.4,
          0.3,
          0.4,
          -0.1,
          -0.1
        ],
        "fcf_avg_yi": -0.17999999999999997,
        "ibd_yi": 3.35,
        "k": 1,
        "k_src": "none",
        "iv_yi": -5.029999999999999
      },
      "revenue_ttm_yi": 0.36,
      "net_margin": -77.8,
      "roe_by_year": {
        "2023": 49.4096,
        "2024": 14.4467,
        "2025": 7.7419
      },
      "roe_avg": 23.87,
      "common_equity_yi": -1.1126,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "02511",
      "name": "君圣泰医药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.095,
      "market_cap_yi": 17.7,
      "ev_yi": 17.1,
      "ee": null,
      "loss": true,
      "ygc": -1.11,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.03,
        "cash_yi": 2.7,
        "np_ttm_yi": -2.71,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.9,
          -1.7,
          -3.6,
          -3,
          -1.7
        ],
        "fcf_avg_yi": -2.1799999999999997,
        "ibd_yi": 1.55,
        "k": 0.953,
        "k_src": "equity",
        "iv_yi": -19.67945
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -808.8889,
        "2024": -67.7565,
        "2025": -67.0063
      },
      "roe_avg": -314.55,
      "common_equity_yi": 1.6701,
      "pb": 10.6,
      "roe_pb": -29.68,
      "watched": false
    },
    {
      "code": "01477",
      "name": "欧康维视生物-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 4.94,
      "market_cap_yi": 34.3,
      "ev_yi": 36.6,
      "ee": null,
      "loss": true,
      "ygc": -1.18,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.99,
        "cash_yi": 2.68,
        "np_ttm_yi": -1.26,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.9,
          -3.2,
          -5.4,
          -4.1,
          -3.6
        ],
        "fcf_avg_yi": -4.040000000000001,
        "ibd_yi": 2.89,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -40.61000000000001
      },
      "revenue_ttm_yi": 9.34,
      "net_margin": -13.5,
      "roe_by_year": {
        "2023": -13.3997,
        "2024": -8.0159,
        "2025": -4.2611
      },
      "roe_avg": -8.56,
      "common_equity_yi": 36.2468,
      "pb": 0.95,
      "roe_pb": -9.04,
      "watched": false
    },
    {
      "code": "00575",
      "name": "励晶太平洋",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.865,
      "market_cap_yi": 2.1,
      "ev_yi": 2.9,
      "ee": null,
      "loss": true,
      "ygc": -1.19,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.8,
        "cash_yi": 0.01,
        "np_ttm_yi": -0.14,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.1,
          0,
          -0.3,
          -0.3,
          -0.3
        ],
        "fcf_avg_yi": -0.2,
        "ibd_yi": 0.5,
        "k": 1,
        "k_src": "none",
        "iv_yi": -2.49
      },
      "revenue_ttm_yi": 0.37,
      "net_margin": -37.8,
      "roe_by_year": {
        "2023": -4789.4837,
        "2024": 120.2899,
        "2025": 75.1076
      },
      "roe_avg": -1531.36,
      "common_equity_yi": -0.4123,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "01952",
      "name": "云顶新耀",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 32.36,
      "market_cap_yi": 97.7,
      "ev_yi": 114.7,
      "ee": null,
      "loss": true,
      "ygc": -1.21,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 32.16,
        "cash_yi": 15.18,
        "np_ttm_yi": -0.54,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -17.1,
          -15.9,
          -10.4,
          -8.8,
          -4.4
        ],
        "fcf_avg_yi": -11.32,
        "ibd_yi": 19.9,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -117.91999999999999
      },
      "revenue_ttm_yi": 24.08,
      "net_margin": -2.2,
      "roe_by_year": {
        "2023": -15.8985,
        "2024": -23.0355,
        "2025": -6.3513
      },
      "roe_avg": -15.1,
      "common_equity_yi": 52.2924,
      "pb": 1.87,
      "roe_pb": -8.08,
      "watched": false
    },
    {
      "code": "02565",
      "name": "派格生物医药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 4.02,
      "market_cap_yi": 13.4,
      "ev_yi": 12,
      "ee": null,
      "loss": true,
      "ygc": -1.21,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.37,
        "cash_yi": 3.76,
        "np_ttm_yi": -3.31,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -1.7,
          -2.3,
          -1.8,
          -1.6
        ],
        "fcf_avg_yi": -1.85,
        "ibd_yi": 1.53,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -16.270000000000003
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -113.9129,
        "2024": -233.9472,
        "2025": -83.2319
      },
      "roe_avg": -143.7,
      "common_equity_yi": 2.6679,
      "pb": 5.02,
      "roe_pb": -28.61,
      "watched": false
    },
    {
      "code": "02561",
      "name": "维昇药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 18.45,
      "market_cap_yi": 17.9,
      "ev_yi": 15,
      "ee": null,
      "loss": true,
      "ygc": -1.31,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.16,
        "cash_yi": 5.06,
        "np_ttm_yi": -2.4,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.3,
          -2.5,
          -2.7,
          -1.4,
          -4.5
        ],
        "fcf_avg_yi": -2.68,
        "ibd_yi": 1.77,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -23.51
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -47.8342,
        "2024": -57.6578,
        "2025": -50.5162
      },
      "roe_avg": -52,
      "common_equity_yi": 6.7125,
      "pb": 2.67,
      "roe_pb": -19.5,
      "watched": false
    },
    {
      "code": "02289",
      "name": "创美药业",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 5.495,
      "market_cap_yi": 5.1,
      "ev_yi": 37.6,
      "ee": 79.9,
      "loss": false,
      "ygc": -1.57,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 33.22,
        "cash_yi": 0.75,
        "np_ttm_yi": 0.47,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          0.4,
          -1.4,
          0.9,
          2.6
        ],
        "fcf_avg_yi": 0.42000000000000004,
        "ibd_yi": 12.97,
        "k": 1,
        "k_src": "profit",
        "iv_yi": -8.02
      },
      "revenue_ttm_yi": 46.78,
      "net_margin": 1,
      "roe_by_year": {
        "2023": 8.6086,
        "2024": 8.7602,
        "2025": 7.4933
      },
      "roe_avg": 8.29,
      "common_equity_yi": 6.0652,
      "pb": 0.84,
      "roe_pb": 9.86,
      "watched": false
    },
    {
      "code": "02592",
      "name": "拨康视云-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.19,
      "market_cap_yi": 9.4,
      "ev_yi": 10.2,
      "ee": null,
      "loss": true,
      "ygc": -2,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.83,
        "cash_yi": 0,
        "np_ttm_yi": -8.39,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          -1.5,
          -1.8,
          -1.9,
          -3.6
        ],
        "fcf_avg_yi": -1.8399999999999999,
        "ibd_yi": 0.44,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -18.84
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": 63.4467,
        "2024": 32.272,
        "2025": 46.4925
      },
      "roe_avg": 47.4,
      "common_equity_yi": 2.8615,
      "pb": 3.28,
      "roe_pb": 14.43,
      "watched": false
    },
    {
      "code": "03681",
      "name": "中国抗体-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.1,
      "market_cap_yi": 13,
      "ev_yi": 14.7,
      "ee": null,
      "loss": true,
      "ygc": -2.06,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.23,
        "cash_yi": 1.52,
        "np_ttm_yi": -1.83,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.6,
          -4.1,
          -2.4,
          -1.7,
          -1
        ],
        "fcf_avg_yi": -2.5599999999999996,
        "ibd_yi": 2.67,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -26.749999999999996
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -60.3884,
        "2024": -75.8007,
        "2025": -29.9619
      },
      "roe_avg": -55.38,
      "common_equity_yi": 3.6152,
      "pb": 3.6,
      "roe_pb": -15.4,
      "watched": false
    },
    {
      "code": "01541",
      "name": "宜明昂科-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 2.98,
      "market_cap_yi": 10.9,
      "ev_yi": 8.5,
      "ee": null,
      "loss": true,
      "ygc": -2.1,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.07,
        "cash_yi": 6.48,
        "np_ttm_yi": -2.3,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.2,
          -2.6,
          -3.7,
          -1.4,
          -2
        ],
        "fcf_avg_yi": -2.58,
        "ibd_yi": 3.53,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -22.85
      },
      "revenue_ttm_yi": 1.42,
      "net_margin": -162,
      "roe_by_year": {
        "2023": -49.6834,
        "2024": -44.2626,
        "2025": -29.732
      },
      "roe_avg": -41.23,
      "common_equity_yi": 6.2594,
      "pb": 1.74,
      "roe_pb": -23.67,
      "watched": false
    },
    {
      "code": "02496",
      "name": "友芝友生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.5,
      "market_cap_yi": 5.8,
      "ev_yi": 7.4,
      "ee": null,
      "loss": true,
      "ygc": -2.14,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.36,
        "cash_yi": 0.76,
        "np_ttm_yi": -0.32,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1,
          -1.8,
          -1.9,
          -1,
          -0.2
        ],
        "fcf_avg_yi": -1.18,
        "ibd_yi": 1.39,
        "k": 1,
        "k_src": "none",
        "iv_yi": -12.43
      },
      "revenue_ttm_yi": 0.63,
      "net_margin": -50.8,
      "roe_by_year": {
        "2023": -135.2223,
        "2024": -123.3954,
        "2025": 753.3742
      },
      "roe_avg": 164.92,
      "common_equity_yi": -0.5856,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "06118",
      "name": "奥星生命科技",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.68,
      "market_cap_yi": 3,
      "ev_yi": 13.9,
      "ee": 82,
      "loss": false,
      "ygc": -2.32,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 13.06,
        "cash_yi": 2.1,
        "np_ttm_yi": 0.17,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.1,
          -1.6,
          -1.3,
          0.8,
          1
        ],
        "fcf_avg_yi": -0.64,
        "ibd_yi": 2.68,
        "k": 0.998,
        "k_src": "equity",
        "iv_yi": -6.9660400000000005
      },
      "revenue_ttm_yi": 16.13,
      "net_margin": 1.1,
      "roe_by_year": {
        "2023": -13.5899,
        "2024": 2.0556,
        "2025": 4.1891
      },
      "roe_avg": -2.45,
      "common_equity_yi": 8.3138,
      "pb": 0.36,
      "roe_pb": -6.79,
      "watched": false
    },
    {
      "code": "00314",
      "name": "思派健康",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.345,
      "market_cap_yi": 8.3,
      "ev_yi": 14.7,
      "ee": null,
      "loss": true,
      "ygc": -2.34,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 7.99,
        "cash_yi": 1.58,
        "np_ttm_yi": -0.09,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -6.4,
          -1.9,
          -1.4,
          -0.7,
          0
        ],
        "fcf_avg_yi": -2.08,
        "ibd_yi": 0.17,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -19.39
      },
      "revenue_ttm_yi": 15.87,
      "net_margin": -0.6,
      "roe_by_year": {
        "2023": -14.8024,
        "2024": -22.7604,
        "2025": -11.4945
      },
      "roe_avg": -16.35,
      "common_equity_yi": 9.3241,
      "pb": 0.89,
      "roe_pb": -18.37,
      "watched": false
    },
    {
      "code": "03390",
      "name": "满贯集团",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.245,
      "market_cap_yi": 1.9,
      "ev_yi": 6.8,
      "ee": 24.2,
      "loss": false,
      "ygc": -2.37,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.13,
        "cash_yi": 0.19,
        "np_ttm_yi": 0.28,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          -0.5,
          0.1,
          -0.7,
          0.9
        ],
        "fcf_avg_yi": -0.12,
        "ibd_yi": 3.56,
        "k": 0.986,
        "k_src": "equity",
        "iv_yi": -4.5060199999999995
      },
      "revenue_ttm_yi": 9.56,
      "net_margin": 2.9,
      "roe_by_year": {
        "2023": 71.6545,
        "2024": 0.6384,
        "2025": 3.0851
      },
      "roe_avg": 25.13,
      "common_equity_yi": 4.7126,
      "pb": 0.4,
      "roe_pb": 62.32,
      "watched": false
    },
    {
      "code": "06955",
      "name": "博安生物",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.03,
      "market_cap_yi": 15.8,
      "ev_yi": 18.8,
      "ee": null,
      "loss": true,
      "ygc": -2.37,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 14.01,
        "cash_yi": 11.05,
        "np_ttm_yi": -0.96,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.9,
          -4.1,
          -3.1,
          -4.8,
          -2.1
        ],
        "fcf_avg_yi": -4,
        "ibd_yi": 8.44,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -37.39
      },
      "revenue_ttm_yi": 6.24,
      "net_margin": -15.4,
      "roe_by_year": {
        "2023": -8.7192,
        "2024": 4.9387,
        "2025": 0.3259
      },
      "roe_avg": -1.15,
      "common_equity_yi": 26.6072,
      "pb": 0.59,
      "roe_pb": -1.94,
      "watched": false
    },
    {
      "code": "06996",
      "name": "德琪医药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.08,
      "market_cap_yi": 18,
      "ev_yi": 18.3,
      "ee": 33.9,
      "loss": false,
      "ygc": -2.76,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 6.06,
        "cash_yi": 5.77,
        "np_ttm_yi": 0.54,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -6.3,
          -6.7,
          -7.8,
          -3.8,
          -1.8
        ],
        "fcf_avg_yi": -5.28,
        "ibd_yi": 2.58,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -49.61
      },
      "revenue_ttm_yi": 5.65,
      "net_margin": 9.6,
      "roe_by_year": {
        "2023": -40.6321,
        "2024": -31.954,
        "2025": -32.0286
      },
      "roe_avg": -34.87,
      "common_equity_yi": 9.1231,
      "pb": 1.97,
      "roe_pb": -17.67,
      "watched": false
    },
    {
      "code": "01228",
      "name": "北海康成-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.885,
      "market_cap_yi": 9.6,
      "ev_yi": 12.6,
      "ee": null,
      "loss": true,
      "ygc": -2.83,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.88,
        "cash_yi": 0.88,
        "np_ttm_yi": -0.82,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -5.9,
          -3.2,
          -3.2,
          -1.2,
          -0.4
        ],
        "fcf_avg_yi": -2.7800000000000002,
        "ibd_yi": 0.29,
        "k": 1,
        "k_src": "none",
        "iv_yi": -27.210000000000004
      },
      "revenue_ttm_yi": 0.56,
      "net_margin": -146.4,
      "roe_by_year": {
        "2023": -281.9074,
        "2024": 172.1329,
        "2025": -3.6308
      },
      "roe_avg": -37.8,
      "common_equity_yi": -1.9593,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "02211",
      "name": "大健康国际",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.415,
      "market_cap_yi": 2,
      "ev_yi": 3,
      "ee": null,
      "loss": true,
      "ygc": -2.85,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 1.03,
        "cash_yi": 0,
        "np_ttm_yi": -0.2,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          -0.2,
          -1,
          -0.6,
          null
        ],
        "fcf_avg_yi": -0.55,
        "ibd_yi": 0.21,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -5.71
      },
      "revenue_ttm_yi": 5.19,
      "net_margin": -3.9,
      "roe_by_year": {
        "2023": 0.1238,
        "2024": -7.7596,
        "2025": -6.2003
      },
      "roe_avg": -4.61,
      "common_equity_yi": 3.4139,
      "pb": 0.59,
      "roe_pb": -7.87,
      "watched": false
    },
    {
      "code": "02410",
      "name": "同源康医药-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.225,
      "market_cap_yi": 10.4,
      "ev_yi": 13.5,
      "ee": null,
      "loss": true,
      "ygc": -2.91,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.08,
        "cash_yi": 1.94,
        "np_ttm_yi": -2.12,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          null,
          -3.1,
          -2.8,
          -3.8,
          -2.6
        ],
        "fcf_avg_yi": -3.0749999999999997,
        "ibd_yi": 1.5,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -30.31
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": 55.0088,
        "2024": 186.3084,
        "2025": -79.3291
      },
      "roe_avg": 54,
      "common_equity_yi": 2.6096,
      "pb": 3.99,
      "roe_pb": 13.55,
      "watched": false
    },
    {
      "code": "00455",
      "name": "天大药业",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.11,
      "market_cap_yi": 2,
      "ev_yi": 4.3,
      "ee": null,
      "loss": true,
      "ygc": -2.96,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.67,
        "cash_yi": 0.34,
        "np_ttm_yi": -0.61,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.4,
          null,
          -1,
          -0.5,
          -0.1
        ],
        "fcf_avg_yi": -0.5,
        "ibd_yi": 1.26,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -5.92
      },
      "revenue_ttm_yi": 3.1,
      "net_margin": -19.7,
      "roe_by_year": {
        "2023": -3.9602,
        "2024": -11.1796,
        "2025": -14.5451
      },
      "roe_avg": -9.89,
      "common_equity_yi": 3.8341,
      "pb": 0.52,
      "roe_pb": -18.97,
      "watched": false
    },
    {
      "code": "06622",
      "name": "兆科眼科-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.1,
      "market_cap_yi": 9.8,
      "ev_yi": 8.3,
      "ee": null,
      "loss": true,
      "ygc": -3.54,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.5,
        "cash_yi": 4.98,
        "np_ttm_yi": -2.15,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -3.4,
          -5.5,
          -4,
          -3,
          -2.6
        ],
        "fcf_avg_yi": -3.7,
        "ibd_yi": 2.67,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -34.69
      },
      "revenue_ttm_yi": 0.35,
      "net_margin": -614.3,
      "roe_by_year": {
        "2023": -17.5149,
        "2024": -12.0299,
        "2025": -12.0244
      },
      "roe_avg": -13.86,
      "common_equity_yi": 13.8816,
      "pb": 0.71,
      "roe_pb": -19.63,
      "watched": false
    },
    {
      "code": "06660",
      "name": "艾美疫苗",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 1.575,
      "market_cap_yi": 16.5,
      "ev_yi": 48,
      "ee": null,
      "loss": true,
      "ygc": -4.1,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 35.28,
        "cash_yi": 1.7,
        "np_ttm_yi": -6.67,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10.5,
          -9.7,
          -4.7,
          -1.4,
          -1.7
        ],
        "fcf_avg_yi": -5.6,
        "ibd_yi": 17.71,
        "k": 0.939,
        "k_src": "equity",
        "iv_yi": -67.61739
      },
      "revenue_ttm_yi": 10.02,
      "net_margin": -66.6,
      "roe_by_year": {
        "2023": -30.2454,
        "2024": -7.9116,
        "2025": -22.0569
      },
      "roe_avg": -20.07,
      "common_equity_yi": 26.3637,
      "pb": 0.63,
      "roe_pb": -32.07,
      "watched": false
    },
    {
      "code": "02179",
      "name": "瑞科生物-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 3.6,
      "market_cap_yi": 19.2,
      "ev_yi": 28.3,
      "ee": null,
      "loss": true,
      "ygc": -4.11,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 10.98,
        "cash_yi": 1.88,
        "np_ttm_yi": -4.82,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -7.1,
          -8.9,
          -8.6,
          -6.4,
          -6
        ],
        "fcf_avg_yi": -7.4,
        "ibd_yi": 6.73,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -78.85000000000001
      },
      "revenue_ttm_yi": 0.02,
      "net_margin": -24100,
      "roe_by_year": {
        "2023": -41.8508,
        "2024": -70.2652,
        "2025": -98.8356
      },
      "roe_avg": -70.32,
      "common_equity_yi": 4.9807,
      "pb": 3.85,
      "roe_pb": -18.24,
      "watched": false
    },
    {
      "code": "01244",
      "name": "思路迪医药股份",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.65,
      "market_cap_yi": 5.8,
      "ev_yi": 9,
      "ee": null,
      "loss": true,
      "ygc": -4.45,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.67,
        "cash_yi": 1.5,
        "np_ttm_yi": -1.73,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4.3,
          -3.3,
          -1.5,
          -2.1,
          -1.6
        ],
        "fcf_avg_yi": -2.5599999999999996,
        "ibd_yi": 1.71,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -25.809999999999995
      },
      "revenue_ttm_yi": 3.57,
      "net_margin": -48.5,
      "roe_by_year": {
        "2023": -55.8266,
        "2024": -21.2177,
        "2025": -25.6958
      },
      "roe_avg": -34.25,
      "common_equity_yi": 5.2499,
      "pb": 1.1,
      "roe_pb": -31,
      "watched": false
    },
    {
      "code": "02126",
      "name": "药明巨诺-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 2.62,
      "market_cap_yi": 9.3,
      "ev_yi": 9.2,
      "ee": null,
      "loss": true,
      "ygc": -4.54,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.81,
        "cash_yi": 3.92,
        "np_ttm_yi": -3.38,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -7,
          -6.4,
          -4.1,
          -3.5,
          -0.8
        ],
        "fcf_avg_yi": -4.36,
        "ibd_yi": 2.55,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -42.23
      },
      "revenue_ttm_yi": 2.89,
      "net_margin": -117,
      "roe_by_year": {
        "2023": -38.0373,
        "2024": -41.4037,
        "2025": -64.3658
      },
      "roe_avg": -47.94,
      "common_equity_yi": 4.524,
      "pb": 2.06,
      "roe_pb": -23.32,
      "watched": false
    },
    {
      "code": "02197",
      "name": "三叶草生物-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.54,
      "market_cap_yi": 17,
      "ev_yi": 26.6,
      "ee": 3.1,
      "loss": false,
      "ygc": -4.68,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 10.43,
        "cash_yi": 0.87,
        "np_ttm_yi": 8.51,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -10,
          -18,
          -7.4,
          -2.9,
          -1.9
        ],
        "fcf_avg_yi": -8.04,
        "ibd_yi": 0.02,
        "k": 1,
        "k_src": "none",
        "iv_yi": -79.54999999999998
      },
      "revenue_ttm_yi": 0,
      "net_margin": null,
      "roe_by_year": {
        "2023": 19.7776,
        "2024": 76.2666,
        "2025": 11.9461
      },
      "roe_avg": 36,
      "common_equity_yi": -8.012,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "06108",
      "name": "新锐医药",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.232,
      "market_cap_yi": 0.4,
      "ev_yi": 0.1,
      "ee": null,
      "loss": true,
      "ygc": -5.95,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.31,
        "cash_yi": 0.64,
        "np_ttm_yi": -0.14,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.5,
          -0.1,
          -0.4,
          0,
          -0.5
        ],
        "fcf_avg_yi": -0.3,
        "ibd_yi": 0.02,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -2.38
      },
      "revenue_ttm_yi": 1.76,
      "net_margin": -8,
      "roe_by_year": {
        "2023": -4.4079,
        "2024": -6.5208,
        "2025": -4.4834
      },
      "roe_avg": -5.14,
      "common_equity_yi": 3.7856,
      "pb": 0.11,
      "roe_pb": -48.62,
      "watched": false
    },
    {
      "code": "00574",
      "name": "百信国际",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.018,
      "market_cap_yi": 0.3,
      "ev_yi": 3.4,
      "ee": null,
      "loss": true,
      "ygc": -5.97,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.18,
        "cash_yi": 0.06,
        "np_ttm_yi": -0.16,
        "period": "2025-12-31",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -0.2,
          0,
          -0.4,
          0,
          -0.1
        ],
        "fcf_avg_yi": -0.14,
        "ibd_yi": 0.45,
        "k": 1,
        "k_src": "none",
        "iv_yi": -1.79
      },
      "revenue_ttm_yi": 0.87,
      "net_margin": -18.4,
      "roe_by_year": {
        "2023": -2.0292,
        "2024": 12.1467,
        "2025": 11.1655
      },
      "roe_avg": 7.09,
      "common_equity_yi": -1.4798,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "09939",
      "name": "开拓药业-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 1.505,
      "market_cap_yi": 6.4,
      "ev_yi": 8.2,
      "ee": null,
      "loss": true,
      "ygc": -9.25,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.1,
        "cash_yi": 0.31,
        "np_ttm_yi": -1.93,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -11.6,
          -9.9,
          -3.9,
          -2,
          -1.7
        ],
        "fcf_avg_yi": -5.819999999999999,
        "ibd_yi": 1.34,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -59.23
      },
      "revenue_ttm_yi": 0.79,
      "net_margin": -244.3,
      "roe_by_year": {
        "2023": -108.6182,
        "2024": -41.2905,
        "2025": -83.9593
      },
      "roe_avg": -77.96,
      "common_equity_yi": 1.0922,
      "pb": 5.86,
      "roe_pb": -13.3,
      "watched": false
    },
    {
      "code": "02170",
      "name": "贝康医疗-B",
      "l1": "药品及生物科技",
      "l2": "H股",
      "price": 1.32,
      "market_cap_yi": 3.1,
      "ev_yi": 4,
      "ee": null,
      "loss": true,
      "ygc": -9.51,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 4.68,
        "cash_yi": 3.74,
        "np_ttm_yi": -1.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -2.3,
          -3.2,
          -3.7,
          -3.2,
          -2.5
        ],
        "fcf_avg_yi": -2.9799999999999995,
        "ibd_yi": 3.42,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -29.479999999999997
      },
      "revenue_ttm_yi": 2.61,
      "net_margin": -66.7,
      "roe_by_year": {
        "2023": -12.8133,
        "2024": -18.6472,
        "2025": -21.5095
      },
      "roe_avg": -17.66,
      "common_equity_yi": 8.6478,
      "pb": 0.36,
      "roe_pb": -49.26,
      "watched": false
    },
    {
      "code": "02137",
      "name": "腾盛博药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.885,
      "market_cap_yi": 5.4,
      "ev_yi": 0.7,
      "ee": null,
      "loss": true,
      "ygc": -10.23,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 0.36,
        "cash_yi": 5.03,
        "np_ttm_yi": -1.75,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -8.8,
          -6.4,
          -6.4,
          -3.8,
          -4.7
        ],
        "fcf_avg_yi": -6.0200000000000005,
        "ibd_yi": 0.06,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -55.230000000000004
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -5.5381,
        "2024": -17.5956,
        "2025": -8.8472
      },
      "roe_avg": -10.66,
      "common_equity_yi": 22.1605,
      "pb": 0.24,
      "roe_pb": -43.75,
      "watched": false
    },
    {
      "code": "02257",
      "name": "圣诺医药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 3.795,
      "market_cap_yi": 3.6,
      "ev_yi": 5.5,
      "ee": null,
      "loss": true,
      "ygc": -10.3,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 2.35,
        "cash_yi": 0.49,
        "np_ttm_yi": -0.74,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4,
          -7.5,
          -5.1,
          -1.4,
          -0.7
        ],
        "fcf_avg_yi": -3.7399999999999998,
        "ibd_yi": 0.18,
        "k": 1,
        "k_src": "none",
        "iv_yi": -37.089999999999996
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -97.0284,
        "2024": -266.8138,
        "2025": 248.4561
      },
      "roe_avg": -38.46,
      "common_equity_yi": -0.413,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "06978",
      "name": "永泰生物-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.385,
      "market_cap_yi": 2,
      "ev_yi": 7.1,
      "ee": null,
      "loss": true,
      "ygc": -11.49,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 5.67,
        "cash_yi": 0.62,
        "np_ttm_yi": -1.72,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4.1,
          -2.7,
          -1.9,
          -1.5,
          -1.1
        ],
        "fcf_avg_yi": -2.26,
        "ibd_yi": 1.01,
        "k": 1,
        "k_src": "none",
        "iv_yi": -22.99
      },
      "revenue_ttm_yi": null,
      "net_margin": null,
      "roe_by_year": {
        "2023": -98.18,
        "2024": -233.1737,
        "2025": 1695.5148
      },
      "roe_avg": 454.72,
      "common_equity_yi": -0.8379,
      "pb": null,
      "roe_pb": null,
      "watched": false
    },
    {
      "code": "06628",
      "name": "创胜集团医药-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.65,
      "market_cap_yi": 2.5,
      "ev_yi": 5.9,
      "ee": null,
      "loss": true,
      "ygc": -12.09,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.39,
        "cash_yi": 0.03,
        "np_ttm_yi": -1.61,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -4,
          -3.2,
          -3.7,
          -2.2,
          -1.4
        ],
        "fcf_avg_yi": -2.9000000000000004,
        "ibd_yi": 1.26,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -30.230000000000004
      },
      "revenue_ttm_yi": 0.28,
      "net_margin": -575,
      "roe_by_year": {
        "2023": -36.9829,
        "2024": -32.6305,
        "2025": -29.7468
      },
      "roe_avg": -33.12,
      "common_equity_yi": 5.5309,
      "pb": 0.45,
      "roe_pb": -73.27,
      "watched": false
    },
    {
      "code": "02487",
      "name": "科笛-B",
      "l1": "药品及生物科技",
      "l2": "非H股",
      "price": 0.86,
      "market_cap_yi": 2.7,
      "ev_yi": 4.8,
      "ee": null,
      "loss": true,
      "ygc": -13.57,
      "triggered": false,
      "fcf_growth": [],
      "detail": {
        "total_liabilities_yi": 3.63,
        "cash_yi": 1.51,
        "np_ttm_yi": -2.81,
        "period": "2026-06-30",
        "fcf_years": [
          "2021",
          "2022",
          "2023",
          "2024",
          "2025"
        ],
        "fcf_by_year": [
          -1.9,
          -3.7,
          -4.4,
          -4.7,
          -3
        ],
        "fcf_avg_yi": -3.54,
        "ibd_yi": 2.74,
        "k": 1,
        "k_src": "equity",
        "iv_yi": -36.63
      },
      "revenue_ttm_yi": 3.33,
      "net_margin": -84.4,
      "roe_by_year": {
        "2023": -3823.4047,
        "2024": -37.3368,
        "2025": -36.5796
      },
      "roe_avg": -1299.11,
      "common_equity_yi": 7.1163,
      "pb": 0.38,
      "roe_pb": -3424.01,
      "watched": false
    }
  ]
}